PF-Atlas › Clinical Trials › NCT06875154
Influence of Original Native Tricuspid Valve Lesion on Post-implant Structural Bioprosthetic Degeneration After Tricuspid Valve Replacement.
Valve replacement · Not specified
Registry ID
NCT06875154
Phase
Not specified
Status
Enrolling by invitation
Drug / intervention
Valve replacement
Sponsor
Maastricht University Medical Center
Start
2024-06-01
Enrollment
500
Locations
1
About this trial
The structural deterioration process of the implanted bioprosthesis in tricuspid position for tricuspid valve pathology is gradual and irreversible and includes many changes, such as pannus growth, leaflet fibrosis and calcification, delamination of the connective tissue, ruptures and perforations of leaflets. In the great majority of cases SVD consists of leaflet calcium deposits and can be clinically associated with young age, hypercholesterolemia, hypertension, diabetes mellitus, renal failure. The long term durability of these bioprosthesis is still missing.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06875154 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.